Robert Hershberg insider trades: Recursion Pharmaceuticals (RXRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
and 2 more companies
Open-market buys and sales
33 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | RXRX | ↓ Sell | 25,000 | $5.00 | $125K | Direct | Oct 7, 2026 (1d) |
| Aug 18, 2026 | ADPT | ↓ Sell | 30,664 | $24.40 | $748K | Direct | Aug 20, 2026 (2d) |
| Jul 7, 2026 | ATAI | ↓ Sell | 100,000 | $4.96 | $496K | Direct | Jul 9, 2026 (2d) |
| Dec 10, 2025 | ADPT | ↓ Sell | 22,968 | $16.00 | $367K | Direct | Dec 12, 2025 (2d) |
| Mar 12, 2025 | ADPT | ↓ Sell | 53,000 | $7.59 | $402K | Direct | Mar 12, 2025 (0d) |
| Feb 11, 2025 | HLVX | ↓ Sell | 26,535 | $1.83 | $49K | Direct | Feb 12, 2025 (1d) |
| Feb 8, 2024 | HLVX | ↓ Sell | 11,597 | $14.93 | $173K | Direct | Feb 12, 2024 (4d) |
| Jun 3, 2022 | FATE | ↓ Sell | 672 | $22.75 | $15K | Direct | Jun 6, 2022 (3d) |
| Apr 15, 2021 | NSTG | ↓ Sell | 144 | $73.91 | $11K | Direct | Apr 19, 2021 (4d) |
| Mar 15, 2021 | NSTG | ↓ Sell | 1,500 | $66.94 | $100K | Direct | Mar 17, 2021 (2d) |
| Mar 8, 2021 | ADPT | ↓ Sell | 2,000 | $44.56 | $89K | Direct | Mar 10, 2021 (2d) |
| Mar 8, 2021 | ADPT | ↓ Sell | 2,000 | $44.56 | $89K | Direct | Mar 10, 2021 (2d) |
| Feb 16, 2021 | NSTG | ↓ Sell | 1,188 | $80.37 | $95K | Direct | Feb 18, 2021 (2d) |
| Feb 16, 2021 | ADPT | ↓ Sell | 2,000 | $65.45 | $131K | Direct | Feb 17, 2021 (1d) |
| Jan 15, 2021 | ADPT | ↓ Sell | 2,000 | $66.56 | $133K | Direct | Jan 20, 2021 (5d) |
| Jan 15, 2021 | NSTG | ↓ Sell | 1,500 | $72.62 | $109K | Direct | Jan 19, 2021 (4d) |
| Dec 15, 2020 | ADPT | ↓ Sell | 2,000 | $55.93 | $112K | Direct | Dec 16, 2020 (1d) |
| Dec 15, 2020 | NSTG | ↓ Sell | 1,500 | $69.33 | $104K | Direct | Dec 16, 2020 (1d) |
| Nov 16, 2020 | ADPT | ↓ Sell | 2,000 | $47.69 | $95K | Direct | Nov 18, 2020 (2d) |
| Nov 16, 2020 | NSTG | ↓ Sell | 1,500 | $46.67 | $70K | Direct | Nov 18, 2020 (2d) |
| Oct 15, 2020 | ADPT | ↓ Sell | 2,000 | $51.51 | $103K | Direct | Oct 16, 2020 (1d) |
| Oct 15, 2020 | NSTG | ↓ Sell | 1,500 | $39.35 | $59K | Direct | Oct 16, 2020 (1d) |
| Sep 15, 2020 | NSTG | ↓ Sell | 1,500 | $43.62 | $65K | Direct | Sep 17, 2020 (2d) |
| Sep 15, 2020 | ADPT | ↓ Sell | 2,000 | $42.58 | $85K | Direct | Sep 16, 2020 (1d) |
| Aug 17, 2020 | ADPT | ↓ Sell | 2,000 | $39.39 | $79K | Direct | Aug 19, 2020 (2d) |
| Aug 17, 2020 | NSTG | ↓ Sell | 1,500 | $38.37 | $58K | Direct | Aug 19, 2020 (2d) |
| Jul 15, 2020 | ADPT | ↓ Sell | 2,000 | $43.84 | $88K | Direct | Jul 17, 2020 (2d) |
| Jul 15, 2020 | NSTG | ↓ Sell | 1,500 | $36.15 | $54K | Direct | Jul 17, 2020 (2d) |
| Jun 15, 2020 | ADPT | ↓ Sell | 2,000 | $43.00 | $86K | Direct | Jun 17, 2020 (2d) |
| Jun 15, 2020 | NSTG | ↓ Sell | 1,500 | $30.79 | $46K | Direct | Jun 17, 2020 (2d) |
| May 15, 2020 | NSTG | ↓ Sell | 10,168 | $30.83 | $313K | Direct | May 18, 2020 (3d) |
| May 15, 2020 | ADPT | ↓ Sell | 2,000 | $34.75 | $69K | Direct | May 18, 2020 (3d) |
| Apr 23, 2020 | ADPT | ↓ Sell | 25,000 | $29.77 | $744K | Direct | Apr 27, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RXRX insiders
Open-market trades in the last 12 months
About Robert Hershberg's insider trades
Robert Hershberg is a director at Recursion Pharmaceuticals (RXRX). Since Apr 23, 2020, Robert has reported no open-market purchases and 33 sales worth $5.4M on SEC Form 4. In the last 12 months: 4 sales ($1.7M).
Their filings also include grants and awards (37 filings), option exercises (31 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RXRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.